| __timestamp | Amneal Pharmaceuticals, Inc. | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 106735000 | 94231000 |
| Thursday, January 1, 2015 | 136870000 | 146394000 |
| Friday, January 1, 2016 | 204747000 | 188272000 |
| Sunday, January 1, 2017 | 191938000 | 166707000 |
| Monday, January 1, 2018 | 210451000 | 401843000 |
| Tuesday, January 1, 2019 | 202287000 | 560909000 |
| Wednesday, January 1, 2020 | 190585000 | 722343000 |
| Friday, January 1, 2021 | 209563000 | 771182000 |
| Saturday, January 1, 2022 | 200046000 | 877090000 |
| Sunday, January 1, 2023 | 167778000 | 877387000 |
Unveiling the hidden dimensions of data
In the competitive world of biopharmaceuticals, innovation is key. Over the past decade, Sarepta Therapeutics, Inc. and Amneal Pharmaceuticals, Inc. have demonstrated contrasting approaches to research and development (R&D) spending. From 2014 to 2023, Sarepta's R&D expenses surged by over 830%, peaking in 2023 with a staggering $877 million. This reflects their aggressive pursuit of cutting-edge therapies, particularly in genetic medicine. In contrast, Amneal's R&D investment remained relatively stable, with a modest 57% increase over the same period, reaching $168 million in 2023. This steady approach suggests a focus on incremental innovation and cost management. The data highlights a strategic divergence: while Sarepta bets big on breakthrough innovations, Amneal opts for a more conservative path. As the biopharma landscape evolves, these strategies will shape their competitive positions and impact on healthcare innovation.
R&D Spending Showdown: Novartis AG vs Sarepta Therapeutics, Inc.
Comparing Innovation Spending: Pfizer Inc. and Amneal Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Regeneron Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Biogen Inc. vs Sarepta Therapeutics, Inc.
Analyzing R&D Budgets: Intra-Cellular Therapies, Inc. vs Sarepta Therapeutics, Inc.
Analyzing R&D Budgets: Dr. Reddy's Laboratories Limited vs Sarepta Therapeutics, Inc.
Research and Development Investment: BioMarin Pharmaceutical Inc. vs Sarepta Therapeutics, Inc.
R&D Spending Showdown: Sarepta Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: Sarepta Therapeutics, Inc. and Mesoblast Limited
Research and Development: Comparing Key Metrics for Amneal Pharmaceuticals, Inc. and Bausch Health Companies Inc.
Amneal Pharmaceuticals, Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Insights: How Amneal Pharmaceuticals, Inc. and Evotec SE Allocate Funds